Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
333
-
Total 13F shares, excl. options
-
64.4M
-
Shares change
-
-2.33M
-
Total reported value, excl. options
-
$3.19B
-
Value change
-
-$114M
-
Put/Call ratio
-
0.43
-
Number of buys
-
148
-
Number of sells
-
-164
-
Price
-
$49.52
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2020
387 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q3 2020.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 333 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.4M shares
of 115M outstanding shares and own 55.84% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.2M shares), VANGUARD GROUP INC (6.67M shares), JANUS HENDERSON GROUP PLC (6.35M shares), WELLINGTON MANAGEMENT GROUP LLP (4.41M shares), STATE STREET CORP (1.86M shares), Van Berkom & Associates Inc. (1.58M shares), AMERIPRISE FINANCIAL INC (1.49M shares), AXA S.A. (1.38M shares), GW&K Investment Management, LLC (1.36M shares), and Standard Life Aberdeen plc (1.3M shares).
This table shows the top 333 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.